Pyxis Oncology, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
PYXS on Nasdaq
Industry
Pharmaceutical Preparations
Location
321 Harrison Avenue, Boston, MA

There are no Buy or Sell transactions made by insiders since 11/5/2023

Pyxis Oncology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pfizer Inc 10%+ Owner $19.4M Mar 17, 2023
Lara Sullivan Chief Executive Officer, Director $7.47M Mar 26, 2024
Barclays Plc 10%+ Owner $4.87M Apr 26, 2022
Bayer World Investments B.V. Former 10% Owner $3.84M Oct 13, 2021
Cormorant Asset Management, LP Former 10% Owner $1.57M Oct 13, 2021
Jakob Dupont Director $1.56M Mar 26, 2024
Pamela Ann Connealy Cfo & Coo $1.55M Mar 26, 2024
Jay Feingold Chief Medical Officer $1.09M Mar 24, 2023
John Flavin Director $578K Mar 26, 2024
Jitendra Wadhane SVP, Chief Accounting Officer $558K Mar 26, 2024
Ken Kobayashi Chief Medical Officer $425K Dec 29, 2023
Darren S. Cline Director $352K Mar 26, 2024
Freda C. Lewis-Hall Director $338K Mar 26, 2024
Michael A. Metzger Director $271K Jun 10, 2024
Santhosh Palani Director $267K Jun 7, 2024
Ronald Herbst Chief Scientific Officer $235K Oct 7, 2021
Thomas Civik Director $169K Mar 26, 2024
Rachel Humphrey Director $136K Mar 26, 2024
Ritu Shah Chief Operating Officer $120K Oct 7, 2021
Mark Chin Former Director Apr 21, 2022

Recent Insider Transactions by Companies or Individuals for Pyxis Oncology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.